TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 311 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $792,853 | +134.6% | 48,110 | +94.3% | 0.00% | +200.0% |
| Q4 2021 | $338,000 | +51.6% | 24,763 | +86.5% | 0.00% | 0.0% |
| Q2 2021 | $223,000 | -32.2% | 13,276 | -26.4% | 0.00% | -50.0% |
| Q1 2021 | $329,000 | -50.7% | 18,029 | -51.8% | 0.00% | -77.8% |
| Q3 2020 | $668,000 | +157.9% | 37,434 | +184.7% | 0.01% | +350.0% |
| Q4 2019 | $259,000 | +12.6% | 13,148 | +16.5% | 0.00% | 0.0% |
| Q1 2019 | $230,000 | – | 11,281 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bartlett & Co. LLC | 20,781 | $296 | 0.01% |
| Valued Wealth Advisors LLC | 231 | $3,574 | 0.00% |
| BALDWIN BROTHERS LLC/MA | 2,035 | $29,039 | 0.00% |